Adverse Drug Reaction News Bulletins
ADR News Bulletin 2012 August (Volume 14 Number 2)
Audiences
Healthcare professional
Industry member
Product type
Therapeutic Products
1 August 2012
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Bulletin Highlights:
Increase in local reports of serious skin reactions related to strontium ranelate (Protos®)
Continuation of the restricted access programme for aprotinin (Trasylol®)
Safety update on statins
Latest updates on the risk of lymphoma with topical calcineurin inhibitors (TCIs)
Alert on counterfeit LIGACLIP® EXTRA LIGATING CLIP CARTRIDGES
Enhancements to the medical device regulatory framework
Updates on Prescription-Only Medicines (POMs) with exemptions for limited sale and supply without prescription
Reports on illegal capsules adulterated with dexamethasone
Acute pancreatitis and serious hypersensitivity reactions reported with saxagliptin
Click on the link below to download the issue in pdf: